|
C20ORF118 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.337900E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.339520E-02 |
| Normal-vs-Stage2 |
2.151400E-01 |
| Normal-vs-Stage3 |
2.790600E-01 |
| Normal-vs-Stage4 |
2.677200E-01 |
| Stage1-vs-Stage2 |
6.307200E-01 |
| Stage1-vs-Stage3 |
2.441000E-01 |
| Stage1-vs-Stage4 |
4.102400E-02 |
| Stage2-vs-Stage3 |
3.542800E-01 |
| Stage2-vs-Stage4 |
2.622800E-01 |
| Stage3-vs-Stage4 |
5.322400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.281100E-03 |
| Normal-vs-AfricanAmerican |
3.222000E-01 |
| Normal-vs-Asian |
7.140600E-01 |
| Caucasian-vs-AfricanAmerican |
6.828600E-01 |
| Caucasian-vs-Asian |
1.373640E-02 |
| AfricanAmerican-vs-Asian |
3.404000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.183800E-02 |
| Normal-vs-Female |
2.918400E-02 |
| Male-vs-Female |
2.974200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.674240E-02 |
| Normal-vs-Age(41-60Yrs) |
1.122390E-01 |
| Normal-vs-Age(61-80Yrs) |
3.533600E-01 |
| Normal-vs-Age(81-100Yrs) |
9.274600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.625240E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.491750E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.744300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.304200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.133800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.075800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.241700E-03 |
| Classical-VS-Follicular |
8.514800E-01 |
| Classical-VS-Other |
3.934400E-01 |
| Classical-VS-Normal |
4.722600E-03 |
| Tall-VS-Follicular |
2.247600E-01 |
| Tall-VS-Other |
3.245400E-01 |
| Tall-VS-Normal |
6.226400E-01 |
| Follicular-VS-Other |
4.117000E-01 |
| Follicular-VS-Normal |
2.540400E-01 |
| Other-VS-Normal |
3.291600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.731700E-02 |
| Normal-vs-N1 |
6.707400E-01 |
| N0-vs-N1 |
1.239620E-01 |
|
|
